$913 Million is the total value of Rhenman & Partners Asset Management AB's 94 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $39,356,000 | +63.7% | 660,000 | +0.6% | 4.31% | +43.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $35,032,000 | +11.2% | 160,000 | -14.0% | 3.84% | -2.8% |
| NVCR | Buy | NOVOCURE LTD | $29,495,000 | +16.0% | 350,000 | +2.9% | 3.23% | +1.4% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $28,055,000 | +0.5% | 775,000 | -24.4% | 3.07% | -12.1% |
| HUM | Buy | HUMANA INC | $24,557,000 | +60.1% | 67,000 | +11.7% | 2.69% | +39.9% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $23,744,000 | +8.6% | 1,100,000 | -8.3% | 2.60% | -5.0% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $21,825,000 | +3.7% | 340,000 | -18.1% | 2.39% | -9.3% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $20,424,000 | +35.7% | 451,668 | +22.1% | 2.24% | +18.6% |
| CI | Buy | CIGNA CORP NEW | $19,427,000 | +60.0% | 95,000 | +18.8% | 2.13% | +39.9% |
| ANTM | Buy | ANTHEM INC | $18,726,000 | +30.0% | 62,000 | +3.3% | 2.05% | +13.6% |
| ABBV | Buy | ABBVIE INC | $18,593,000 | +44.4% | 210,000 | +23.5% | 2.04% | +26.3% |
| ABT | Sell | ABBOTT LABS | $18,021,000 | -2.2% | 207,469 | -5.7% | 1.98% | -14.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $17,756,000 | -9.3% | 210,000 | -27.7% | 1.95% | -20.7% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $17,155,000 | +170.2% | 500,000 | -41.2% | 1.88% | +136.2% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $17,051,000 | +1.9% | 58,000 | -24.7% | 1.87% | -10.9% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $16,919,000 | +85.3% | 700,000 | +47.4% | 1.85% | +61.9% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $16,108,000 | +106.8% | 125,000 | +25.0% | 1.76% | +80.7% |
| MYOK | Buy | MYOKARDIA INC | $15,306,000 | +46.7% | 210,000 | +5.0% | 1.68% | +28.2% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $15,284,000 | -36.9% | 141,319 | -42.9% | 1.68% | -44.8% |
| LIVN | Buy | LIVANOVA PLC | $15,086,000 | +70.4% | 200,000 | +66.7% | 1.65% | +48.9% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $15,048,000 | -21.7% | 100,805 | -32.8% | 1.65% | -31.6% |
| ABMD | Sell | ABIOMED INC | $14,841,000 | -30.5% | 87,000 | -27.5% | 1.63% | -39.2% |
| IMMU | Sell | IMMUNOMEDICS INC | $14,812,000 | +31.4% | 700,000 | -17.6% | 1.62% | +14.9% |
| LLY | Sell | LILLY ELI & CO | $14,647,000 | -12.7% | 111,446 | -25.7% | 1.60% | -23.7% |
| MRK | Sell | MERCK & CO INC | $14,552,000 | -19.6% | 160,000 | -25.6% | 1.60% | -29.7% |
| MDT | Sell | MEDTRONIC PLC | $14,185,000 | -29.5% | 125,030 | -32.5% | 1.55% | -38.4% |
| SGEN | Sell | SEATTLE GENETICS INC | $13,711,000 | +8.0% | 120,000 | -19.3% | 1.50% | -5.6% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $13,148,000 | +38.9% | 475,000 | -8.7% | 1.44% | +21.5% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $12,899,000 | -4.3% | 120,000 | -19.8% | 1.41% | -16.3% |
| GKOS | Buy | GLAUKOS CORP | $12,800,000 | -10.8% | 235,000 | +2.4% | 1.40% | -22.0% |
| GH | Buy | GUARDANT HEALTH INC | $12,133,000 | +443.1% | 155,268 | +343.6% | 1.33% | +375.0% |
| DERM | Buy | DERMIRA INC | $12,128,000 | +245.5% | 800,000 | +45.6% | 1.33% | +202.0% |
| FGEN | Sell | FIBROGEN INC | $11,795,000 | +8.1% | 275,000 | -6.8% | 1.29% | -5.5% |
| MGNX | Buy | MACROGENICS INC | $11,533,000 | +13.1% | 1,060,000 | +32.6% | 1.26% | -1.2% |
| XNCR | Buy | XENCOR INC | $10,661,000 | +4.5% | 310,000 | +2.5% | 1.17% | -8.7% |
| EPZM | Sell | EPIZYME INC | $10,455,000 | +125.2% | 425,000 | -5.6% | 1.15% | +96.9% |
| CVS | Sell | CVS HEALTH CORP | $10,416,000 | -45.6% | 140,214 | -53.8% | 1.14% | -52.5% |
| HCA | Sell | HCA HEALTHCARE INC | $10,347,000 | +14.6% | 70,000 | -6.7% | 1.13% | +0.2% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $10,138,000 | -18.8% | 27,000 | -40.0% | 1.11% | -29.1% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $9,992,000 | +40.9% | 220,000 | +41.9% | 1.10% | +23.2% |
| EXAS | Sell | EXACT SCIENCES CORP | $9,895,000 | +1.6% | 107,000 | -0.7% | 1.08% | -11.2% |
| BDX | Sell | BECTON DICKINSON & CO | $9,247,000 | -42.0% | 34,000 | -46.0% | 1.01% | -49.3% |
| AXNX | New | AXONICS MODULATION TECH INC | $9,144,000 | – | 330,000 | +100.0% | 1.00% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $8,865,000 | +10.2% | 38,000 | +3.9% | 0.97% | -3.8% |
| CNC | Sell | CENTENE CORP DEL | $8,802,000 | +16.3% | 140,000 | -20.0% | 0.96% | +1.7% |
| AMRN | AMARIN CORP PLCspons adr new | $8,576,000 | +41.4% | 400,000 | 0.0% | 0.94% | +23.7% | |
| SILK | Buy | SILK ROAD MEDICAL INC | $8,455,000 | +107.9% | 209,381 | +67.5% | 0.93% | +81.8% |
| STML | Buy | STEMLINE THERAPEUTICS INC | $8,081,000 | +51.9% | 760,181 | +48.8% | 0.89% | +32.8% |
| OMCL | Buy | OMNICELL INC | $7,763,000 | +19.4% | 95,000 | +5.6% | 0.85% | +4.4% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $7,640,000 | -3.8% | 160,000 | -34.7% | 0.84% | -15.9% |
| ALKS | Buy | ALKERMES PLC | $7,548,000 | +75.9% | 370,000 | +68.2% | 0.83% | +53.7% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $7,488,000 | +1048.5% | 650,000 | +443.1% | 0.82% | +901.2% |
| ISRG | New | INTUITIVE SURGICAL INC | $7,094,000 | – | 12,000 | +100.0% | 0.78% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $6,993,000 | +26.0% | 60,715 | -12.0% | 0.77% | +10.1% |
| GTHX | Sell | G1 THERAPEUTICS INC | $6,962,000 | -42.9% | 263,400 | -50.8% | 0.76% | -50.1% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $6,805,000 | – | 125,000 | +100.0% | 0.75% | – |
| COO | New | COOPER COS INC | $6,426,000 | – | 20,000 | +100.0% | 0.70% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $6,178,000 | +40.0% | 1,080,000 | -12.5% | 0.68% | +22.4% |
| BIIB | New | BIOGEN INC | $5,935,000 | – | 20,000 | +100.0% | 0.65% | – |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $5,859,000 | -11.9% | 700,000 | -4.7% | 0.64% | -23.0% |
| INCY | New | INCYTE CORP | $5,676,000 | – | 65,000 | +100.0% | 0.62% | – |
| XLRN | Buy | ACCELERON PHARMA INC | $5,302,000 | +91.7% | 100,000 | +42.9% | 0.58% | +67.4% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $5,021,000 | +60.7% | 150,000 | +0.5% | 0.55% | +40.3% |
| BLUE | Buy | BLUEBIRD BIO INC | $5,002,000 | +4.8% | 57,000 | +9.6% | 0.55% | -8.5% |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $4,957,000 | +56.9% | 40,000 | -16.0% | 0.54% | +37.1% |
| QURE | New | UNIQURE NV | $4,300,000 | – | 60,000 | +100.0% | 0.47% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $4,066,000 | +8.7% | 1,900,000 | -5.0% | 0.45% | -4.9% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $4,058,000 | +79.5% | 250,000 | +43.7% | 0.44% | +57.2% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $3,895,000 | +26.9% | 140,000 | -1.5% | 0.43% | +10.9% |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $3,830,000 | – | 191,300 | +100.0% | 0.42% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $3,610,000 | +28.7% | 50,000 | +150.0% | 0.40% | +12.5% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $3,513,000 | – | 178,073 | +100.0% | 0.38% | – |
| RDUS | Buy | RADIUS HEALTH INC | $3,427,000 | -11.3% | 170,000 | +13.3% | 0.38% | -22.3% |
| BGNE | New | BEIGENE LTDsponsored adr | $3,315,000 | – | 20,000 | +100.0% | 0.36% | – |
| ABEO | ABEONA THERAPEUTICS INC | $3,270,000 | +44.7% | 1,000,000 | 0.0% | 0.36% | +26.5% | |
| VRAY | Buy | VIEWRAY INC | $3,165,000 | +71.7% | 750,000 | +18.0% | 0.35% | +50.2% |
| RGNX | New | REGENXBIO INC | $3,073,000 | – | 75,000 | +100.0% | 0.34% | – |
| CLLS | New | CELLECTIS S Asponsored adr | $2,476,000 | – | 144,604 | +100.0% | 0.27% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $2,450,000 | – | 80,000 | +100.0% | 0.27% | – |
| VKTX | VIKING THERAPEUTICS INC | $1,604,000 | +16.6% | 200,000 | 0.0% | 0.18% | +2.3% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,086,000 | +6.2% | 300,000 | 0.0% | 0.12% | -7.0% | |
| CVX | CHEVRON CORP | $358,000 | +1.4% | 2,974 | 0.0% | 0.04% | -11.4% | |
| QCOM | QUALCOMM INC | $299,000 | +15.4% | 3,391 | 0.0% | 0.03% | +3.1% | |
| DIS | DISNEY WALT CO | $301,000 | +11.1% | 2,083 | 0.0% | 0.03% | -2.9% | |
| IBM | INTERNATIONAL BUSINESS MACHS | $297,000 | -7.8% | 2,215 | 0.0% | 0.03% | -17.5% | |
| JPM | Sell | JPMORGAN CHASE & CO | $292,000 | +0.3% | 2,095 | -15.3% | 0.03% | -11.1% |
| WFC | WELLS FARGO CO NEW | $284,000 | +6.8% | 5,272 | 0.0% | 0.03% | -6.1% | |
| F | FORD MTR CO DEL | $271,000 | +1.5% | 29,164 | 0.0% | 0.03% | -9.1% | |
| XOM | EXXON MOBIL CORP | $269,000 | -1.1% | 3,854 | 0.0% | 0.03% | -14.7% | |
| JHG | JANUS HENDERSON GROUP PLC | $260,000 | +8.8% | 10,645 | 0.0% | 0.03% | -6.7% | |
| BUD | Sell | ANHEUSER-BUSCH INBEV SA/NVsponsored adr | $230,000 | -29.0% | 2,806 | -17.7% | 0.02% | -39.0% |
| NLOK | New | NORTONLIFELOCK INC | $224,000 | – | 8,761 | +100.0% | 0.02% | – |
| GOOGL | New | ALPHABET INCcap stk cl a | $214,000 | – | 160 | +100.0% | 0.02% | – |
| HAL | New | HALLIBURTON CO | $203,000 | – | 8,299 | +100.0% | 0.02% | – |
| SYMC | Exit | Symantec Corp | $0 | – | -8,761 | -100.0% | -0.03% | – |
| MSFT | Exit | Microsoft Corp | $0 | – | -1,532 | -100.0% | -0.03% | – |
| SNSS | Exit | Sunesis Pharmaceuticals Inc Reg | $0 | – | -377,244 | -100.0% | -0.03% | – |
| ACHN | Exit | Achillion Pharmaceuticals Inc | $0 | – | -277,800 | -100.0% | -0.12% | – |
| ARQL | Exit | ArQule Inc Reg | $0 | – | -200,000 | -100.0% | -0.18% | – |
| MDGL | Exit | Madrigal Pharmaceuticals Inc Reg | $0 | – | -30,000 | -100.0% | -0.32% | – |
| HMSY | Exit | HMS Holdings Corp Reg | $0 | – | -98,300 | -100.0% | -0.42% | – |
| DPLO | Exit | Diplomat Pharmacy Inc Reg | $0 | – | -1,060,000 | -100.0% | -0.65% | – |
| EXEL | Exit | Exelixis Inc | $0 | – | -320,000 | -100.0% | -0.71% | – |
| RARX | Exit | Ra Pharmaceuticals Inc Reg | $0 | – | -244,000 | -100.0% | -0.72% | – |
| CHRS | Exit | Coherus BioSciences Inc | $0 | – | -290,000 | -100.0% | -0.74% | – |
| Exit | Incyte Corp Ltd | $0 | – | -80,000 | -100.0% | -0.74% | – | |
| MDCO | Exit | Medicines Co | $0 | – | -153,000 | -100.0% | -0.96% | – |
| ABC | Exit | AmerisourceBergen Corp | $0 | – | -99,000 | -100.0% | -1.02% | – |
| TMO | Exit | Thermo Fisher Scientific Inc | $0 | – | -38,000 | -100.0% | -1.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.